Logo image of ICAD.PA

ICADE (ICAD.PA) Stock Fundamental Analysis

EPA:ICAD - Euronext Paris - Matif - FR0000035081 - REIT - Currency: EUR

23.56  -0.12 (-0.51%)

Fundamental Rating

3

Overall ICAD gets a fundamental rating of 3 out of 10. We evaluated ICAD against 41 industry peers in the Diversified REITs industry. ICAD may be in some trouble as it scores bad on both profitability and health. ICAD is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ICAD was profitable.
ICAD had a positive operating cash flow in the past year.
In multiple years ICAD reported negative net income over the last 5 years.
In the past 5 years ICAD always reported a positive cash flow from operatings.
ICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

The Return On Assets of ICAD (-2.62%) is worse than 82.93% of its industry peers.
ICAD has a Return On Equity of -6.38%. This is amonst the worse of the industry: ICAD underperforms 85.37% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.77%, ICAD is doing worse than 80.49% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ICAD is in line with the industry average of 3.55%.
Industry RankSector Rank
ROA -2.62%
ROE -6.38%
ROIC 1.77%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ICAD.PA Yearly ROA, ROE, ROICICAD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

The Operating Margin of ICAD (13.47%) is worse than 87.80% of its industry peers.
ICAD's Operating Margin has declined in the last couple of years.
ICAD does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 13.47%
PM (TTM) N/A
GM N/A
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICAD.PA Yearly Profit, Operating, Gross MarginsICAD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

3

2. Health

2.1 Basic Checks

ICAD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ICAD has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ICAD has been increased compared to 5 years ago.
ICAD has a worse debt/assets ratio than last year.
ICAD.PA Yearly Shares OutstandingICAD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ICAD.PA Yearly Total Debt VS Total AssetsICAD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

ICAD has an Altman-Z score of 0.84. This is a bad value and indicates that ICAD is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ICAD (0.84) is worse than 60.98% of its industry peers.
ICAD has a debt to FCF ratio of 28.49. This is a negative value and a sign of low solvency as ICAD would need 28.49 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 28.49, ICAD is doing worse than 68.29% of the companies in the same industry.
A Debt/Equity ratio of 0.99 indicates that ICAD is somewhat dependend on debt financing.
ICAD has a worse Debt to Equity ratio (0.99) than 75.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 28.49
Altman-Z 0.84
ROIC/WACC0.6
WACC2.95%
ICAD.PA Yearly LT Debt VS Equity VS FCFICAD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.84 indicates that ICAD should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.84, ICAD belongs to the top of the industry, outperforming 87.80% of the companies in the same industry.
A Quick Ratio of 1.55 indicates that ICAD should not have too much problems paying its short term obligations.
ICAD has a Quick ratio of 1.55. This is amongst the best in the industry. ICAD outperforms 87.80% of its industry peers.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 1.55
ICAD.PA Yearly Current Assets VS Current LiabilitesICAD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.06% over the past year.
Measured over the past years, ICAD shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.69% on average per year.
Looking at the last year, ICAD shows a decrease in Revenue. The Revenue has decreased by -5.13% in the last year.
ICAD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.64% yearly.
EPS 1Y (TTM)12.06%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-83.39%
Revenue 1Y (TTM)-5.13%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-0.77%

3.2 Future

Based on estimates for the next years, ICAD will show a decrease in Earnings Per Share. The EPS will decrease by -0.73% on average per year.
Based on estimates for the next years, ICAD will show a decrease in Revenue. The Revenue will decrease by -1.82% on average per year.
EPS Next Y7.14%
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%
EPS Next 5YN/A
Revenue Next Year-8.73%
Revenue Next 2Y-3.15%
Revenue Next 3Y-1.82%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICAD.PA Yearly Revenue VS EstimatesICAD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ICAD.PA Yearly EPS VS EstimatesICAD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

ICAD is valuated cheaply with a Price/Earnings ratio of 7.46.
Compared to the rest of the industry, the Price/Earnings ratio of ICAD indicates a rather cheap valuation: ICAD is cheaper than 90.24% of the companies listed in the same industry.
ICAD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.29.
Based on the Price/Forward Earnings ratio of 6.96, the valuation of ICAD can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ICAD indicates a rather cheap valuation: ICAD is cheaper than 97.56% of the companies listed in the same industry.
ICAD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.17.
Industry RankSector Rank
PE 7.46
Fwd PE 6.96
ICAD.PA Price Earnings VS Forward Price EarningsICAD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ICAD is valued a bit cheaper than the industry average as 68.29% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ICAD is valued a bit cheaper than the industry average as 65.85% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.81
EV/EBITDA 15.37
ICAD.PA Per share dataICAD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

ICAD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.04
PEG (5Y)N/A
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.80%, ICAD is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.44, ICAD has a dividend in line with its industry peers.
ICAD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 4.8%

5.2 History

The dividend of ICAD has a limited annual growth rate of 1.04%.
Dividend Growth(5Y)1.04%
Div Incr Years1
Div Non Decr Years1
ICAD.PA Yearly Dividends per shareICAD.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

ICAD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-132.91%
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%
ICAD.PA Yearly Income VS Free CF VS DividendICAD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

ICADE

EPA:ICAD (6/3/2025, 4:39:43 PM)

23.56

-0.12 (-0.51%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18 2025-02-18/amc
Earnings (Next)07-23 2025-07-23
Inst Owners72.42%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.80B
Analysts70.48
Price Target25.79 (9.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.8%
Yearly Dividend4.84
Dividend Growth(5Y)1.04%
DP-132.91%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.97%
PT rev (3m)-8.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.64%
Revenue NY rev (3m)-6.49%
Valuation
Industry RankSector Rank
PE 7.46
Fwd PE 6.96
P/S 1.14
P/FCF 10.81
P/OCF 4.9
P/B 0.42
P/tB 0.42
EV/EBITDA 15.37
EPS(TTM)3.16
EY13.41%
EPS(NY)3.39
Fwd EY14.37%
FCF(TTM)2.18
FCFY9.25%
OCF(TTM)4.81
OCFY20.4%
SpS20.62
BVpS56.72
TBVpS56.26
PEG (NY)1.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.62%
ROE -6.38%
ROCE 2.53%
ROIC 1.77%
ROICexc 1.97%
ROICexgc 1.98%
OM 13.47%
PM (TTM) N/A
GM N/A
FCFM 10.57%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ROICexc(3y)2.49%
ROICexc(5y)2.67%
ROICexgc(3y)2.5%
ROICexgc(5y)2.68%
ROCE(3y)3.06%
ROCE(5y)3.38%
ROICexcg growth 3Y-8.78%
ROICexcg growth 5Y2.92%
ROICexc growth 3Y-8.79%
ROICexc growth 5Y2.96%
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 28.49
Debt/EBITDA 13.44
Cap/Depr 187.28%
Cap/Sales 12.74%
Interest Coverage 2.79
Cash Conversion 115%
Profit Quality N/A
Current Ratio 1.84
Quick Ratio 1.55
Altman-Z 0.84
F-Score7
WACC2.95%
ROIC/WACC0.6
Cap/Depr(3y)678.24%
Cap/Depr(5y)1255.8%
Cap/Sales(3y)20.42%
Cap/Sales(5y)31.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.06%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-83.39%
EPS Next Y7.14%
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.13%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-0.77%
Revenue Next Year-8.73%
Revenue Next 2Y-3.15%
Revenue Next 3Y-1.82%
Revenue Next 5YN/A
EBIT growth 1Y-17.53%
EBIT growth 3Y-29.53%
EBIT growth 5Y-3.23%
EBIT Next Year45.89%
EBIT Next 3Y14.53%
EBIT Next 5Y8.7%
FCF growth 1Y4516.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.88%
OCF growth 3Y-11.53%
OCF growth 5Y-0.14%